Nectar Lifesciences Limited submitted a revised disclosure to the National Stock Exchange of India Limited and BSE Limited regarding the proceedings of its 31st Annual General Meeting (AGM). This filing is a continuation of a previous disclosure (letter no. NLL/CS/2026-730 dated September 18, 2026) and is made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The purpose is to correct an inadvertent error in the cut-off date mentioned in the original AGM proceedings.

The 31st AGM was held on Friday, September 18, 2026, at 11:00 A.M. IST through Video Conferencing (VC)/Other Audio Visual Means (OAVM). The meeting was conducted in compliance with MCA General Circulars (Nos. 14/2020, 17/2020, 20/2020, and the latest being 03/2025 dated September 22, 2025) and relevant SEBI circulars dated May 12, 2020, January 15, 2021, May 13, 2022, January 5, 2023, October 07, 2023, and October 3, 2024.

Attendees

Directors Present:

  • Mr. Sanjiv Goyal- Chairman & Managing Director
  • Dr. Indu Pal Kaur- Independent Director
  • Dr. Kuldeep Kumar Bhasin- Independent Director and Chairperson of Stakeholders Relationship Committee
  • Dr. Rupinder Tewari- Independent Director and Chairperson of Audit Committee and Nomination & Remuneration Committee
  • Mr. Sushil Kapoor- Whole-time Director & Chief Financial Officer
  • Dr. Gunmala Suri- Additional Non-Executive Non-Independent Director

In Attendance:

  • Mr. Deepak Jindal- Partner of M/s. Deepak Jindal & Co., Chartered Accountants (Statutory Auditors)
  • Mr. Prince Chadha- Proprietor of P. Chadha & Associates., Company Secretaries (Secretarial Auditors)
  • Mr. Sanjaymohan Singh Rawat- Company Secretary & Compliance Officer

Key Proceedings

The Company Secretary welcomed attendees, and Mr. Sanjiv Goyal chaired the meeting. The Chairman confirmed that quorum was present and that all feasible efforts were made to enable member participation via VC and electronic voting.

The Statutory Auditors (M/s. Deepak Jindal & Co.) and Secretarial Auditors (P. Chadha & Associates) had expressed unqualified opinions in their respective audit reports for FY 2025-2026. There were no qualifications, observations, or adverse comments on the financial statements.

Voting Details

KFin Technologies Limited served as the Registrar & Share Transfer Agent (RTA) and provided the electronic voting facility. The remote e-voting period was from Tuesday, September 15, 2026, at 9:00 A.M. to Thursday, September 17, 2026, at 5:00 P.M. An Insta Poll (e-voting at the AGM) was also conducted for members present who had not participated in remote e-voting.

The cut-off date for determining eligibility to vote was Friday, September 11, 2026. Mr. Prince Chadha was appointed as the Scrutinizer to scrutinize the remote e-voting and Insta Poll in a fair and transparent manner. The voting results were to be notified to the stock exchanges within two working days of the meeting's conclusion, in the format prescribed under Regulation 44(3) of the LODR Regulations, and uploaded on the company's and KFin's websites.

Resolutions Passed

Ordinary Business:

1. To receive, consider, and adopt the Standalone and Consolidated Financial Statements of the Company for the financial year ended March 31, 2026, along with the Reports of the Board of Directors and Auditors.

2. To re-appoint Mr. Sanjiv Goyal (DIN: 00002841), who retired by rotation.

Special Business:

3. To re-appoint Dr. Kuldip Kumar Bhasin (DIN: 09250008) as an Independent Director for a second consecutive five-year term.

4. To re-appoint Dr. Indu Pal Kaur (DIN: 09686862) as an Independent Director for a second consecutive five-year term.

5. To appoint Dr. Gunmala Suri (DIN: 11879344) as a Non-Executive Non-Independent Director.

The meeting concluded at 11:25 A.M. IST. The Chairman appreciated the team's efforts and thanked the members for their trust.